<p>2025 年 10 月 22 日- 下午 06:30</p>
<p>特拉华州威尔明顿，2025 年 10 月 22 日（GLOBE NEWSWIRE）-- Aimfinity Investment Corp. I（“公司” 或 “AIMA”）（OTC: AIMTF），一家注册为开曼群岛豁免公司的特殊目的收购公司，今天宣布，关于将于 2025 年 10 月 27 日举行的股东特别大会（“会议”），公司提供了以下关于与会议相关的赎回的问答：</p>
<p><strong><em>问：如果您撤回或撤销之前与 Docter 业务合并相关的赎回请求，以便在此次特别会议上赎回您的股份，而我们在特别会议之前完成 Docter 业务合并，或者我们不举行特别会议，会怎样？</em></strong></p>
<p><strong><em>答：</em></strong> <em>如代理声明中其他地方所述，如果您之前选择在业务合并 EGM 中赎回您的股份，但现在希望在与此次特别会议/章程修正提案相关的情况下赎回您的股份，您需要撤回或撤销之前提交给公司的赎回请求，并选择在此次特别会议上赎回您的股份。</em></p>
<p><em>然而，如果我们在特别会议之前完成 Docter 业务合并，则无法保证我们会举行特别会议并实施提案。</em></p>
<p><em>因此，具体情况取决于事件的时间和顺序：</em></p>
<ul>
<li><strong><em>如果我们在此次特别会议之前完成 Docter 业务合并，则特别会议和提案将不会实施</em></strong> _：</li>
</ul>
<ul>
<li><em>任何最初与 Docter 业务合并相关提交的赎回请求将在 Docter 业务合并完成时自动赎回。即使您已撤回或撤销该请求以便在此次特别会议上赎回，您与 Docter 业务合并相关提交的赎回请求仍将被处理。</em></li>
</ul>
<ul>
<li><em>任何未最初提交与 Docter 业务合并相关的赎回请求的公众股份将不会被赎回，并将被取消并根据业务合并协议交换为 PubCo 普通股。</em></li>
<li><strong><em>如果我们在此次特别会议之前未完成 Docter 业务合并，并且在 2025 年 10 月 28 日之前不举行特别会议并实施提案</em></strong> <em>，我们将（1）停止所有运营，除非是为了清算；（2）在合理可能的情况下，但不超过十个工作日内，完成所有已发行和流通的公众股份的赎回；（3）在赎回后尽快进行清算和解散，前提是 AIMA 在赎回后获得剩余股东和董事会的批准，并遵守开曼群岛法律对债权人索赔和其他适用法律要求的义务。</em></li>
</ul>
<ul>
<li><strong><em>如果在 2025 年 10 月 28 日之前组织了特别会议并实施了提案，无论 Docter 业务合并是否完成：</em></strong></li>
</ul>
<ul>
<li><em>与此次特别会议相关提交的任何赎回请求（包括在撤回/撤销与 Docter 业务合并相关的之前赎回请求后提交的赎回请求）将在特别会议和章程修正通过后执行。</em></li>
</ul>
<ul>
<li><em>与 Docter 业务合并相关的任何最初提交的赎回请求，如果在此次特别会议上未撤回或撤销，将保持有效，待 Docter 业务合并完成。</em></li>
</ul>
<ul>
<li><em>任何未提交与 Docter 业务合并或此次特别会议相关的赎回请求的公众股份将不会被赎回，如果我们完成 Docter 业务合并，将被取消并交换为 PubCo 普通股，或者如果我们无法及时完成业务合并并停止所有运营，则将被赎回。</em></li>
</ul>
<p><em>公司正在与各方合作，以符合纳斯达克上市的资格，目前无法预测 Docter 业务合并何时会完成。如果完成，公司将在 Docter 业务合并完成前至少提前 2 个工作日通过新闻稿宣布拟定的关闭日期。</em></p>
<p>公司将延长公众股东提交赎回请求或撤销请求的截止日期，从 2025 年 10 月 23 日星期四，东部时间下午 5:00，延长至 2025 年 10 月 27 日星期一，东部时间上午 11:00。</p>
<p>特别会议的地点、目的或任何待处理提案没有变化。特别会议的实际地点仍为台湾屏东县屏东市公园路 25 号 3 楼，并通过电话会议进行，您必须提前注册：<em>https://forms.cloud.microsoft/r/pMLPzcu46r.</em></p>
<p>确定有权收到会议通知和投票的公司股东的记录日期仍为 2025 年 9 月 29 日营业结束时。记录日期时的股东如果之前已提交代理或以其他方式投票且不想更改投票，则无需采取任何行动。尚未投票的股东被鼓励尽快投票。</p>
<p>有关更多信息，您可以参考公司将在 2025 年 10 月 22 日左右向证券交易委员会（“SEC”）提交的 8-K 表格当前报告。</p>
<p>如果您对您的持股证明或股份交付有任何疑问，请联系：</p>
<p>Vstock Transfer LLC</p>
<p>18 Lafayette Place</p>
<p>Woodmere, NY 11598</p>
<p>收件人：行动团队</p>
<p>对于会议或投票影响有疑问的股东，或希望请求文件的股东，可以联系公司的代理征集人 Advantage Proxy, Inc.，电话为 (877) 870-8565，银行和经纪人可以拨打 (206) 870-8565，或通过电子邮件联系 ksmith@advantageproxy.com。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含根据 1995 年美国私人证券诉讼改革法案的安全港条款定义的 “前瞻性声明”。某些前瞻性声明可以通过使用诸如 “相信”、“期望”、“打算”、“计划”、“估计”、“假设”、“可能”、“应该”、“将”、“寻求” 或其他类似表达的词语来识别。这些声明可能包括但不限于关于会议的延期、会议日期以及提交赎回请求的截止日期延长的声明。这些声明基于本新闻稿发布之日的当前预期，并涉及可能导致实际结果显著不同的一系列风险和不确定性。公司不承担更新或修订任何此类前瞻性声明的义务，无论是由于新发展还是其他原因。读者应谨慎对待前瞻性声明。</p>
<p><strong>附加信息及获取途径</strong></p>
<p>2024 年 12 月 11 日，公司向 SEC 提交了与会议相关的代理声明（Schedule 14-A“代理声明”）。公司投资者和证券持有者被敦促在代理声明（包括任何修订或补充）及公司向 SEC 提交的其他文件可用时，仔细阅读这些文件的全部内容，因为它们将包含重要信息。</p>
<p>投资者和证券持有者可以通过 SEC 维护的网站 www.sec.gov 免费获取代理声明（包括任何修订或补充）及其他提交给 SEC 的文件，或联系代理征集人：</p>
<p>Advantage Proxy, Inc.</p>
<p>P.O.Box 10904</p>
<p>Yakima, WA 98909</p>
<p>免费电话： (877) 870-8565</p>
<p>收费电话： (206) 870-8565</p>
<p>电子邮件： ksmith@advantageproxy.com</p>
<p><strong>征集参与者</strong></p>
<p>公司及其各自的董事和高管可能被视为在与特别会议相关的股东代理征集中的参与者。有关这些潜在参与者的身份及其直接或间接利益（通过证券持有或其他方式）的更多信息已在代理声明中列出。您可以使用上述来源免费获取这些文件的副本。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVMU1EVTNNeU0zTWpFd05EQTVJelV3TURFeE56Y3hOZz09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVMU1EVTNNeU0zTWpFd05EQTVJelV3TURFeE56Y3hOZz09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZWNlNmFmM2QtZjRjNi00ZmY3LWFkNmItOTg4MDBiY2YzMjZkLTUwMDExNzcxNi0yMDI1LTEwLTIyLWVu/tiny/Aimfinity-Investment-Corp-I.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZWNlNmFmM2QtZjRjNi00ZmY3LWFkNmItOTg4MDBiY2YzMjZkLTUwMDExNzcxNi0yMDI1LTEwLTIyLWVu/tiny/Aimfinity-Investment-Corp-I.png"/></p>

AIMAU

<p>Aimfinity Investment Corp. I 已明确其赎回程序，准备于 2025 年 10 月 27 日召开特别股东大会。希望撤回与 Docter 业务合并相关的先前赎回请求的股东，必须在即将召开的会议上进行赎回。如果在会议之前完成 Docter 业务合并，先前的赎回请求将相应处理。股东提交或撤回赎回请求的截止日期已延长至 2025 年 10 月 27 日东部时间上午 11:00。会议将在台湾进行现场会议和虚拟会议</p>

<p>10/22/2025 - 06:30 PM</p>
<div class="lb-trans"><p>2025 年 10 月 22 日- 下午 06:30</p>
</div><p>Wilmington, DE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “Company” or “AIMA”) (OTC: AIMTF), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in connection with its extraordinary general meeting of shareholders to be organized on October 27, 2025 (the “Meeting”), the Company has provided the following Q&amp;A regarding redemptions in connection with the Meeting:</p>
<div class="lb-trans"><p>特拉华州威尔明顿，2025 年 10 月 22 日（GLOBE NEWSWIRE）-- Aimfinity Investment Corp. I（“公司” 或 “AIMA”）（OTC: AIMTF），一家注册为开曼群岛豁免公司的特殊目的收购公司，今天宣布，关于将于 2025 年 10 月 27 日举行的股东特别大会（“会议”），公司提供了以下关于与会议相关的赎回的问答：</p>
</div><p><strong><em>Q: What if you reverse or withdraw your previous redemption request in connection with the Docter Business Combination in order to redeem your shares in connection with this Extraordinary Meeting and we complete the Docter Business Combination prior to the Extraordinary Meeting or we do not hold the Extraordinary Meeting?</em></strong></p>
<div class="lb-trans"><p><strong><em>问：如果您撤回或撤销之前与 Docter 业务合并相关的赎回请求，以便在此次特别会议上赎回您的股份，而我们在特别会议之前完成 Docter 业务合并，或者我们不举行特别会议，会怎样？</em></strong></p>
</div><p><strong><em>A:</em></strong> <em>As provided elsewhere in the proxy statement, if you have elected to redeem your shares in connection with the Business Combination EGM previously but wish to redeem your shares now in connection with the Extraordinary Meeting/Charter Amendment Proposal, you need to reverse or withdraw your redemption request previously submitted to the Company, and elect to redeem your shares in connection with this Extraordinary Meeting.</em></p>
<div class="lb-trans"><p><strong><em>答：</em></strong> <em>如代理声明中其他地方所述，如果您之前选择在业务合并 EGM 中赎回您的股份，但现在希望在与此次特别会议/章程修正提案相关的情况下赎回您的股份，您需要撤回或撤销之前提交给公司的赎回请求，并选择在此次特别会议上赎回您的股份。</em></p>
</div><p><em>However, there is no assurance that we will hold the Extraordinary Meeting and implement the Proposals, if, for example, we consummate the Docter Business Combination prior to the Extraordinary Meeting.</em></p>
<div class="lb-trans"><p><em>然而，如果我们在特别会议之前完成 Docter 业务合并，则无法保证我们会举行特别会议并实施提案。</em></p>
</div><p><em>Therefore, depending on the timing and sequence of the events:</em></p>
<div class="lb-trans"><p><em>因此，具体情况取决于事件的时间和顺序：</em></p>
</div><ul>
<li><strong><em>If we consummate the Docter Business Combination prior to this Extraordinary Meeting, the Extraordinary Meeting and the Proposals will not be implemented</em></strong> <em>:</em></li>
</ul>
<div class="lb-trans"><ul>
<li><strong><em>如果我们在此次特别会议之前完成 Docter 业务合并，则特别会议和提案将不会实施</em></strong> _：</li>
</ul>
</div><ul>
<li><em>Any redemption request originally submitted in connection with the Docter Business Combination will automatically be redeemed in connection with the consummation of the Docter Business Combination. Even if you have reversed or withdrawn such request in order to redeem in connection with this Extraordinary Meeting, your redemption request tendered in connection with the Docter Business Combination will still be processed.</em></li>
</ul>
<div class="lb-trans"><ul>
<li><em>任何最初与 Docter 业务合并相关提交的赎回请求将在 Docter 业务合并完成时自动赎回。即使您已撤回或撤销该请求以便在此次特别会议上赎回，您与 Docter 业务合并相关提交的赎回请求仍将被处理。</em></li>
</ul>
</div><ul>
<li><em>Any public shares not originally tendered for redemptions in connection with the Docter Business Combination will not be redeemed, and will be cancelled and exchanged into such PubCo Ordinary Shares as contemplated under the Business Combination Agreement.</em></li>
<li><strong><em>If we do not consummate the Docter Business Combination prior to this Extraordinary Meeting and do not hold the Extraordinary Meeting and implement the Proposals on or before October 28, 2025</em></strong> <em>, we will (1) cease all operations, except for the purpose of winding up; (2) as promptly as reasonably possible but not more than tenbusinessdays thereafter, complete the redemption of all issued and outstanding public shares; (3) as promptly as reasonably possible following such redemption and subject to the approval of AIMA’s remaining shareholders after such redemption and the Board, liquidate and dissolve, subject in each case to AIMA’s obligations under Cayman Islands law to provide for claims of creditors and other requirements of applicable law.</em></li>
</ul>
<div class="lb-trans"><ul>
<li><em>任何未最初提交与 Docter 业务合并相关的赎回请求的公众股份将不会被赎回，并将被取消并根据业务合并协议交换为 PubCo 普通股。</em></li>
<li><strong><em>如果我们在此次特别会议之前未完成 Docter 业务合并，并且在 2025 年 10 月 28 日之前不举行特别会议并实施提案</em></strong> <em>，我们将（1）停止所有运营，除非是为了清算；（2）在合理可能的情况下，但不超过十个工作日内，完成所有已发行和流通的公众股份的赎回；（3）在赎回后尽快进行清算和解散，前提是 AIMA 在赎回后获得剩余股东和董事会的批准，并遵守开曼群岛法律对债权人索赔和其他适用法律要求的义务。</em></li>
</ul>
</div><ul>
<li><strong><em>If the Extraordinary Meeting is organized and the Proposals are implemented on or before October 28, 2025, irrespective of when or whether the Docter Business Combination is consummated:</em></strong></li>
</ul>
<div class="lb-trans"><ul>
<li><strong><em>如果在 2025 年 10 月 28 日之前组织了特别会议并实施了提案，无论 Docter 业务合并是否完成：</em></strong></li>
</ul>
</div><ul>
<li><em>Any redemption request submitted in connection with this Extraordinary Meeting (including any redemption requests submitted after reversal/withdrawal of previous redemptions tendered in connection with the Docter Business Combination) will be effectuated and executed following the Extraordinary Meeting and adoption of the Charter Amendment.</em></li>
</ul>
<div class="lb-trans"><ul>
<li><em>与此次特别会议相关提交的任何赎回请求（包括在撤回/撤销与 Docter 业务合并相关的之前赎回请求后提交的赎回请求）将在特别会议和章程修正通过后执行。</em></li>
</ul>
</div><ul>
<li><em>Any redemption requests originally submitted in connection with the Docter Business Combination and not reversed or withdrawn in connection with this Extraordinary Meeting will remain outstanding, pending the consummation of the Docter Business Combination.</em></li>
</ul>
<div class="lb-trans"><ul>
<li><em>与 Docter 业务合并相关的任何最初提交的赎回请求，如果在此次特别会议上未撤回或撤销，将保持有效，待 Docter 业务合并完成。</em></li>
</ul>
</div><ul>
<li><em>Any public shares not tendered for redemptions in connection with the Docter Business Combination or in connection with this Extraordinary Meeting will not be redeemed, and will be cancelled and exchanged into such PubCo Ordinary Shares if we complete the Docter Business Combination, or redeemed if we cannot complete a business combination timely and cease all operations.</em></li>
</ul>
<div class="lb-trans"><ul>
<li><em>任何未提交与 Docter 业务合并或此次特别会议相关的赎回请求的公众股份将不会被赎回，如果我们完成 Docter 业务合并，将被取消并交换为 PubCo 普通股，或者如果我们无法及时完成业务合并并停止所有运营，则将被赎回。</em></li>
</ul>
</div><p><em>The Company is working with the parties to qualify for Nasdaq listing and cannot predict at this time when it expects the Docter Business Combination will be consummated, if at all. The Company will announce the proposed date of closing in a press release at least 2 business days before the Docter Business Combination will be consummated.</em></p>
<div class="lb-trans"><p><em>公司正在与各方合作，以符合纳斯达克上市的资格，目前无法预测 Docter 业务合并何时会完成。如果完成，公司将在 Docter 业务合并完成前至少提前 2 个工作日通过新闻稿宣布拟定的关闭日期。</em></p>
</div><p>The Company will extend the deadline for the Company’s public shareholders to deliver their redemption requests or reversals from Thursday, October 23, 2025, 5:00 p.m. Eastern Time to Monday, October 27, 2025, 11:00 a.m. Eastern Time.</p>
<div class="lb-trans"><p>公司将延长公众股东提交赎回请求或撤销请求的截止日期，从 2025 年 10 月 23 日星期四，东部时间下午 5:00，延长至 2025 年 10 月 27 日星期一，东部时间上午 11:00。</p>
</div><p>There is no change to the location, the purpose or any of the proposals to be acted upon at the Extraordinary Meeting. The physical location of the Extraordinary Meeting remains at 3F., No.25, Gongyuan Rd., Pingtung City, Pingtung County, Taiwan (R.O.C.), and virtually via teleconference, for which you must register in advanceat: <em>https://forms.cloud.microsoft/r/pMLPzcu46r.</em></p>
<div class="lb-trans"><p>特别会议的地点、目的或任何待处理提案没有变化。特别会议的实际地点仍为台湾屏东县屏东市公园路 25 号 3 楼，并通过电话会议进行，您必须提前注册：<em>https://forms.cloud.microsoft/r/pMLPzcu46r.</em></p>
</div><p>The Record Date for determining the Company shareholders entitled to receive notice of and to vote at the Meeting remains the close of business on September 29, 2025. Shareholders as of the Record Date who have previously submitted their proxies or otherwise voted and who do not want to change their vote need not take any action. Shareholders who have not yet done so are encouraged to vote as soon as possible.</p>
<div class="lb-trans"><p>确定有权收到会议通知和投票的公司股东的记录日期仍为 2025 年 9 月 29 日营业结束时。记录日期时的股东如果之前已提交代理或以其他方式投票且不想更改投票，则无需采取任何行动。尚未投票的股东被鼓励尽快投票。</p>
</div><p>For further information, you may refer to the current report on Form 8-K to be filed by the Company with the Securities and Exchange Commission (the “SEC”) on or around October 22, 2025.</p>
<div class="lb-trans"><p>有关更多信息，您可以参考公司将在 2025 年 10 月 22 日左右向证券交易委员会（“SEC”）提交的 8-K 表格当前报告。</p>
</div><p>If you have questions regarding the certification of your position or delivery of your shares, please contact:</p>
<div class="lb-trans"><p>如果您对您的持股证明或股份交付有任何疑问，请联系：</p>
</div><p>Vstock Transfer LLC</p>
<div class="lb-trans"><p>Vstock Transfer LLC</p>
</div><p>18 Lafayette Place</p>
<div class="lb-trans"><p>18 Lafayette Place</p>
</div><p>Woodmere, NY 11598</p>
<div class="lb-trans"><p>Woodmere, NY 11598</p>
</div><p>Attn: Action Team</p>
<div class="lb-trans"><p>收件人：行动团队</p>
</div><p>Shareholders who have questions regarding the Meeting or the impact on the votes casted, or would like to request documents may contact the Company’s proxy solicitor, Advantage Proxy, Inc., at (877) 870-8565, or banks and brokers can call (206) 870-8565, or by email atksmith@advantageproxy.com.</p>
<div class="lb-trans"><p>对于会议或投票影响有疑问的股东，或希望请求文件的股东，可以联系公司的代理征集人 Advantage Proxy, Inc.，电话为 (877) 870-8565，银行和经纪人可以拨打 (206) 870-8565，或通过电子邮件联系 ksmith@advantageproxy.com。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press releaseincludes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements may include, but are not limited to, statements regarding the adjournment, the date of the Meeting and the extension of the deadline to deliver a redemption request. These statements are based on current expectations on the date of this press releaseand involve a number of risks and uncertainties that may cause actual results to differ significantly. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1995 年美国私人证券诉讼改革法案的安全港条款定义的 “前瞻性声明”。某些前瞻性声明可以通过使用诸如 “相信”、“期望”、“打算”、“计划”、“估计”、“假设”、“可能”、“应该”、“将”、“寻求” 或其他类似表达的词语来识别。这些声明可能包括但不限于关于会议的延期、会议日期以及提交赎回请求的截止日期延长的声明。这些声明基于本新闻稿发布之日的当前预期，并涉及可能导致实际结果显著不同的一系列风险和不确定性。公司不承担更新或修订任何此类前瞻性声明的义务，无论是由于新发展还是其他原因。读者应谨慎对待前瞻性声明。</p>
</div><p><strong>Additional Information and Where to Find It</strong></p>
<div class="lb-trans"><p><strong>附加信息及获取途径</strong></p>
</div><p>On December 11, 2024, the Company filed the proxy statement on Schedule 14-A (“Proxy Statement”) with the SEC in connection with its solicitation of proxies for the Meeting. INVESTORS AND SECURITY HOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER DOCUMENTS THE COMPANY FILES WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION.</p>
<div class="lb-trans"><p>2024 年 12 月 11 日，公司向 SEC 提交了与会议相关的代理声明（Schedule 14-A“代理声明”）。公司投资者和证券持有者被敦促在代理声明（包括任何修订或补充）及公司向 SEC 提交的其他文件可用时，仔细阅读这些文件的全部内容，因为它们将包含重要信息。</p>
</div><p>Investors and security holders will be able to obtain free copies of the Proxy Statement (including any amendments or supplements thereto) and other documents filed with the SEC through the web site maintained by the SEC atwww.sec.govor contact proxy solicitor:</p>
<div class="lb-trans"><p>投资者和证券持有者可以通过 SEC 维护的网站 www.sec.gov 免费获取代理声明（包括任何修订或补充）及其他提交给 SEC 的文件，或联系代理征集人：</p>
</div><p>Advantage Proxy, Inc.</p>
<div class="lb-trans"><p>Advantage Proxy, Inc.</p>
</div><p>P.O.Box 10904</p>
<div class="lb-trans"><p>P.O.Box 10904</p>
</div><p>Yakima, WA98909</p>
<div class="lb-trans"><p>Yakima, WA 98909</p>
</div><p>Toll Free: (877) 870-8565</p>
<div class="lb-trans"><p>免费电话： (877) 870-8565</p>
</div><p>Collect: (206) 870-8565</p>
<div class="lb-trans"><p>收费电话： (206) 870-8565</p>
</div><p>Email: ksmith@advantageproxy.com</p>
<div class="lb-trans"><p>电子邮件： ksmith@advantageproxy.com</p>
</div><p><strong>Participants in the Solicitation</strong></p>
<div class="lb-trans"><p><strong>征集参与者</strong></p>
</div><p>The Company and its respective directors and officers may be deemed to be participants in the solicitation of proxies from shareholders in connection with theExtraordinary Meeting. Additional information regarding the identity of these potential participants and their direct or indirect interests, by security holdings or otherwise, is set forth in the Proxy Statement. You may obtain free copies of these documents using the sources indicated above.</p>
<div class="lb-trans"><p>公司及其各自的董事和高管可能被视为在与特别会议相关的股东代理征集中的参与者。有关这些潜在参与者的身份及其直接或间接利益（通过证券持有或其他方式）的更多信息已在代理声明中列出。您可以使用上述来源免费获取这些文件的副本。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVMU1EVTNNeU0zTWpFd05EQTVJelV3TURFeE56Y3hOZz09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTU1MDU3MyM3MjEwNDA5IzUwMDExNzcxNg=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZWNlNmFmM2QtZjRjNi00ZmY3LWFkNmItOTg4MDBiY2YzMjZkLTUwMDExNzcxNi0yMDI1LTEwLTIyLWVu/tiny/Aimfinity-Investment-Corp-I.png" alt="" original-src="https://ml.globenewswire.com/media/ZWNlNmFmM2QtZjRjNi00ZmY3LWFkNmItOTg4MDBiY2YzMjZkLTUwMDExNzcxNi0yMDI1LTEwLTIyLWVu/tiny/Aimfinity-Investment-Corp-I.png"/></p>

Aimfinity Investment Corp. I 宣布关于股东大会赎回程序的澄清 | AIMAU 股票新闻